INTRAVENOUS ENOXACIN FOR THE TREATMENT OF ACUTE PYELONEPHRITIS - PHARMACOKINETIC AND CLINICAL-STUDY

被引:1
作者
BAILEY, RR
WALKER, RJ
LYNN, KL
DONALDSON, IM
PEDDIE, BA
DOBBS, BR
机构
[1] CHRISTCHURCH SCH MED, DEPT NEUROL, CHRISTCHURCH, NEW ZEALAND
[2] MRC, TOXICOL RES UNIT, DUNEDIN, NEW ZEALAND
关键词
D O I
10.1111/j.1365-2125.1988.tb03294.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:223 / 228
页数:6
相关论文
共 7 条
[1]  
BAILEY RR, 1985, NEW ZEAL MED J, V98, P286
[2]   INVITRO ACTIVITY OF CI-919 (AT-2266), AN ORAL ANTI-PSEUDONOMAL COMPOUND [J].
CHARTRAND, SA ;
SCRIBNER, RK ;
WEBER, AH ;
WELCH, DF ;
MARKS, MI .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (05) :658-663
[3]   INVITRO ACTIVITY OF ENOXACIN, A QUINOLONE CARBOXYLIC-ACID, COMPARED WITH THOSE OF NORFLOXACIN, NEW BETA-LACTAMS, AMINOGLYCOSIDES, AND TRIMETHOPRIM [J].
CHIN, NX ;
NEU, HC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (05) :754-763
[4]  
DOBBS BR, 1987, IN PRESS EUR J CLIN, V32
[5]   INVITRO AND INVIVO ANTI-BACTERIAL ACTIVITY OF AT-2266 [J].
KOUNO, K ;
INOUE, M ;
MITSUHASHI, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (01) :78-84
[6]   INVITRO ANTI-BACTERIAL PROPERTIES OF AT-2266, A NEW PYRIDONECARBOXYLIC ACID [J].
NAKAMURA, S ;
MINAMI, A ;
KATAE, H ;
INOUE, S ;
YAMAGISHI, J ;
TAKASE, Y ;
SHIMIZU, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (05) :641-648
[7]  
PEDDIE BA, 1984, AUST MICROBIOL, V5, P192